表紙
市場調查報告書
商品編碼
1019138

全球血友病市場規模調查:各疾病類型,各治療法,各產品類型,各地區預測(2021∼2027年)

Global Hemophilia Market Size study, by Disease Type, by Therapy, by Product Type, and Regional Forecasts 2021-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球血友病市場2020年約124億美金。

全球血友病的市場規模,預計從2021年到2027年的預測期間以約5.5%健全成長率成長,至2027年預計達到180億美元。

全球血友病市場受到出血性疾病日益流行和政府有利舉措的推動。此外,近年來與血友病治療相關的研發活動與新產品開發相結合,將為全球血友病行業提供新的機遇。然而,高昂的治療成本可能會阻礙2021-2027年預測期內的市場成長。

本報告提供全球血友病市場相關調查,市場概要,以及各疾病類型,各治療法,各產品類型,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球血友病市場定義和範圍

第3章 全球血友病市場動態

  • 血友病市場影響分析(2019∼2027年)

第4章 全球血友病市場產業分析

  • 波特的5力模式
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球血友病市場,各疾病類型

  • 市場概述
  • 全球血友病市場,各疾病類型:效能-潛力分析
  • 全球血友病市場預算與預測,各疾病類型:2018∼2027年(10億美元)
  • 血友病市場,子區隔分析
    • A型血友病
    • B型血友病
    • 其他

第6章 全球血友病市場,各治療法

  • 市場概述
  • 全球血友病市場,各治療法:效能-潛力分析
  • 全球血友病市場預算與預測,各治療法:2018∼2027年(10億美元)
  • 血友病市場,子區隔分析
    • 補充療法
    • 基因治療
    • 其他

第7章 全球血友病市場,各產品類型

  • 市場概述
  • 全球血友病市場,各產品類型:效能-潛力分析
  • 全球血友病市場預算與預測,各產品類型:2018∼2027年(10億美元)
  • 血友病市場,子區隔分析
    • 組換凝固凝血因子濃縮劑
    • 血漿來源凝固凝血因子濃縮劑
    • 其他

第8章 全球血友病市場,地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他地區

第9章 競爭資訊

  • 最高市場策略
  • 企業簡介
    • Bayer AG
    • BioMarin Pharmaceutical, Inc.
    • CSL Behring
    • Kedrion S.p.A
    • Novo Nordisk
    • Pfizer, Inc.
    • Roche(Chugai Pharmaceutical Co.)
    • Sanofi(Genzyme Corporation)
    • Takeda Pharmaceutical(Shire Plc.)
    • Genentech

第10章 調查流程

目錄

Global hemophilia market is expected to reach $18 billion by 2027. Global hemophilia market is valued approximately at $12.4 billion in 2020 and is anticipated to grow with a healthy growth rate of about 5.5% over the forecast period 2021-2027. Hemophilia is a bleeding disorder in which blood clotting does not occur properly and leads to spontaneous bleeding followed by injuries and surgeries. The global hemophilia marketis being driven by growing prevalence of bleeding disorders and favorable government initiatives. Furthermore, there have been research and development activities coupled with new product developmentin recent years related to hemophilia treatment whichwill provide new opportunities for the global hemophilia industry. For instance, according to the American Association for the Advancement of Science, in 2020, researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) announced the development of an optimized cellular platform to deliver Factor 8 to offer better treatment to patients with hemophilia A. Also, in 2018, RCSI (University of Medicine and Health Sciences) and Bayer AG entered into a research collaboration aimed atenhancingtreatments for people experiencing severe hemophilia. The collaboration also aimed to explore new treatment methods that can effectively and safely promote blood clotting in people experiencing hemophilia. Such research and development activities related to hemophilia is expected to drive the market growth during the forecast period. However,high cost of treatmentmay impede market growth over the forecast period of 2021-2027.

The regional analysis of the global hemophilia market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to increasing therapeutic advancements in hemophilia,increasing prevalence of hemophilia,advancements in gene therapy,etc. in the region. Whereas Asia Pacificis anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to earlydisease diagnosis in countries,etc. across the region.

Major market player included in this report are:

Bayer AG

BioMarin Pharmaceutical, Inc.

CSL Behring

Kedrion S.p.A

Novo Nordisk

Pfizer, Inc.

Roche (Chugai Pharmaceutical Co.)

Sanofi (Genzyme Corporation)

Takeda Pharmaceutical (Shire Plc.)

Genentech

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Hemophilia A

Hemophilia B

Others

By Therapy:

Replacement Therapy

Gene Therapy

Others

By Product Type:

Recombinant Coagulation Factor Concentrates

Plasma-derived Coagulation Factor Concentrates

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Hemophilia Marketin Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Hemophilia Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Hemophilia Market, by Disease Type, 2019-2027 (USD Billion)
    • 1.2.3. Hemophilia Market, by Therapy, 2019-2027 (USD Billion)
    • 1.2.4. Hemophilia Market, by Product Type, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Hemophilia Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Hemophilia Market Dynamics

  • 3.1. Hemophilia Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of bleeding disorders
      • 3.1.1.2. Favourable government initiatives
    • 3.1.2. Market Restraint
      • 3.1.2.1. High cost of treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising R&D and new product development

Chapter 4. Global Hemophilia Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Hemophilia Market, by Disease Type

a. Market Snapshot

  • 5.1. Global Hemophilia Market by Disease Type, Performance - Potential Analysis
  • 5.2. Global Hemophilia Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)
  • 5.3. Hemophilia Market, Sub Segment Analysis
    • 5.3.1. Hemophilia A
    • 5.3.2. Hemophilia B
    • 5.3.3. Others

Chapter 6. Global Hemophilia Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Hemophilia Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Hemophilia Market Estimates & Forecasts by Therapy 2018-2027 (USD Billion)
  • 6.4. Hemophilia Market, Sub Segment Analysis
    • 6.4.1. Replacement Therapy
    • 6.4.2. Gene Therapy
    • 6.4.3. Others

Chapter 7. Global Hemophilia Market, by Product Type

  • 7.1. Market Snapshot
  • 7.2. Global Hemophilia Market by Product Type, Performance - Potential Analysis
  • 7.3. Global Hemophilia Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)
  • 7.4. Hemophilia Market, Sub Segment Analysis
    • 7.4.1. Recombinant Coagulation Factor Concentrates
    • 7.4.2. Plasma-derived Coagulation Factor Concentrates
    • 7.4.3. Others

Chapter 8. Global Hemophilia Market, Regional Analysis

  • 8.1. Hemophilia Market, Regional Market Snapshot
  • 8.2. North America Hemophilia Market
    • 8.2.1. U.S. Hemophilia Market
      • 8.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027
      • 8.2.1.2. Therapy breakdown estimates & forecasts, 2018-2027
      • 8.2.1.3. Product Type breakdown estimates & forecasts, 2018-2027
    • 8.2.2. Canada Hemophilia Market
  • 8.3. Europe Hemophilia Market Snapshot
    • 8.3.1. U.K. Hemophilia Market
    • 8.3.2. Germany Hemophilia Market
    • 8.3.3. France Hemophilia Market
    • 8.3.4. Spain Hemophilia Market
    • 8.3.5. Italy Hemophilia Market
    • 8.3.6. Rest of Europe Hemophilia Market
  • 8.4. Asia-Pacific Hemophilia Market Snapshot
    • 8.4.1. China Hemophilia Market
    • 8.4.2. India Hemophilia Market
    • 8.4.3. Japan Hemophilia Market
    • 8.4.4. Australia Hemophilia Market
    • 8.4.5. South Korea Hemophilia Market
    • 8.4.6. Rest of Asia Pacific Hemophilia Market
  • 8.5. Latin America Hemophilia Market Snapshot
    • 8.5.1. Brazil Hemophilia Market
    • 8.5.2. Mexico Hemophilia Market
  • 8.6. Rest of The World Hemophilia Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bayer AG
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. BioMarin Pharmaceutical, Inc.
    • 9.2.3. CSL Behring
    • 9.2.4. Kedrion S.p.A
    • 9.2.5. Novo Nordisk
    • 9.2.6. Pfizer, Inc.
    • 9.2.7. Roche (Chugai Pharmaceutical Co.)
    • 9.2.8. Sanofi (Genzyme Corporation)
    • 9.2.9. Takeda Pharmaceutical (Shire Plc.)
    • 9.2.10. Genentech

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 2. Global Hemophilia Market, report scope
  • TABLE 3. Global Hemophilia Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 4. Global Hemophilia Market estimates & forecasts by Disease Type2018-2027 (USD Billion)
  • TABLE 5. Global Hemophilia Market estimates & forecasts by Therapy 2018-2027 (USD Billion)
  • TABLE 6. Global Hemophilia Market estimates & forecasts by Product Type 2018-2027 (USD Billion)
  • TABLE 7. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Global Hemophilia Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. Global Hemophilia Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. U.S. Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. U.S. Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. U.S. Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Canada Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Canada Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. UK Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. UK Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. Germany Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. Germany Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. France Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. France Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Spain Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Spain Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. Italy Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Italy Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. ROE Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. ROE Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. China Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. China Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. India Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. India Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Japan Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Japan Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 57. Australia Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. Australia Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South Korea Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 60. South Korea Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 61. South Korea Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 63. ROPAC Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 64. ROPAC Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 66. Brazil Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 67. Brazil Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 69. Mexico Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 70. Mexico Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 72. ROLA Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 73. ROLA Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Hemophilia Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 75. ROW Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 76. ROW Hemophilia Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 77. List of secondary sources used in the study of global Hemophilia Market.
  • TABLE 78. List of primary sources used in the study of global Hemophilia Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Global Hemophilia Market, research methodology
  • FIG 2. Global Hemophilia Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Hemophilia Market, key trends 2020
  • FIG 5. Global Hemophilia Market, growth prospects 2021-2027
  • FIG 6. Global Hemophilia Market, porters 5 force model
  • FIG 7. Global Hemophilia Market, pest analysis
  • FIG 8. Global Hemophilia Market, value chain analysis
  • FIG 9. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Hemophilia Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Hemophilia Market, regional snapshot 2018 & 2027
  • FIG 18. North America Hemophilia Market2018 & 2027 (USD Billion)
  • FIG 19. Europe Hemophilia Market2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Hemophilia Market2018 & 2027 (USD Billion)
  • FIG 21. Latin America Hemophilia Market2018 & 2027 (USD Billion)
  • FIG 22. Global Hemophilia Market, company market share analysis (2020)